Top Markets
Coin of the day
Fuse Medical, Inc. Fuse Medical, Inc.

Fuse Medical, Inc.

FZMD
Rangering i aksjer #37740
Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based... Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.
Aksjekurs
$0.02
Sist synkronisert: 2026-08-13
Markedsverdi
$1.48M
Endring (1 dag)
0.00%
Endring (1 år)
-71.43%
Land
US
Handel Fuse Medical, Inc. (FZMD)

Kategori

Inntekter for Fuse Medical, Inc. (FZMD)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Fuse Medical, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Fuse Medical, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
$6.51B -
US